MMJ Recs

JANUARY 17, 2024

Cannabis can also enhance the efficacy of conventional treatments, potentially allowing patients to reduce reliance on traditional pharmaceuticals with a myriad of side effects. Patients need to have a documented medical condition, such as arthritis, that falls within the state’s approved list of qualifying conditions.

Strains 98

Strains Marijuana Indica Microdosing 98

Canna Care Docs

SEPTEMBER 18, 2020

To prepare for your appointment you will want to collect your medical records about the condition you wish to treat with medical cannabis. This can be as simple as taking a picture of a prescription bottle you have been given to treat your condition. What Conditions Qualify for Medical Marijuana Cards in Virginia?

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Cannabis Law Report

JULY 29, 2021

With Avicanna’s dedication to quality standards and pharmaceutical positioning we are poised to be a significant long-term player in the European medical market that is predominantly focused on medical utility of cannabinoids and where meeting EU pharmacopeia standards are essential.”.

Extraction 98

Extraction Supply Chain THC Research and Development 98

The Cannigma

AUGUST 5, 2022

When antidepressants were first introduced in the mid-20 th century, they were a breakthrough in pharmaceuticals. Nue Life is a telemedicine company that provides ketamine experiences for people with treatment-resistant depression and other mental health conditions. But this program offers more than just the ketamine itself.

Treatment 138

Treatment Research and Development Therapy Digestion 138

Cannabis Law Report

AUGUST 11, 2021

Under the Licensing Agreement, which has an initial three-year term, Avicanna has exclusively licensed, subject to certain conditions and exceptions, the use of certain proprietary product formulations to Heritage to be marketed and sold under Heritage’s medical Opticann branded products in non-competing medical channels in Canada. “We

Topical 98

Topical Research and Development Seed-To-Sale Pharmaceutical 98

Veriheal

JUNE 29, 2021

Plant medicines and concoctions made from them have been utilized throughout the history of cultures around the world. In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine. A Push by Patients.

Therapy 55

Therapy DEA Patients Clinical Trials 55

SpeedWeed

AUGUST 11, 2021

The grant comes from Michigan’s 2021 Veteran Marijuana Research Grant Program , and is funded by the state’s recreational cannabis taxes. With a goal of determining the “the efficacy of marijuana in treating the medical conditions of United States armed services veterans and preventing veteran suicide.”. MAPS Makes History.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Canna Law Blog

NOVEMBER 27, 2021

Also, according to the DEA, “the history of human experience probably goes back several hundred years since DMT usage is associated with a number of religious practices and rituals.” Several months ago, Canada-based Algernon Pharmaceuticals submitted a request to U.S. This research—as with psilocybin, MDMA, ketamine, ibogaine etc.—is

Therapy 91

Therapy Clinical Trials DEA Microdosing 91

Cannabis Law Report

JUNE 16, 2021

. “Santé is a key partner to for Wake as they are a leading contract research organization (CRO) in Canada with expertise in advancing plant-based pharmaceutical products through various phases of clinical trial development. Santé Cannabis is at the forefront of safe and supported patient access to complementary medicines.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. By Brett Mulligan.

Access 52

Access Patients Research and Development Treatment 52

Veriheal

AUGUST 11, 2021

This generation is also on track to become the most educated generation yet with the majority being likely to enroll in post-high school programs. Gen Z women are not only using cannabis recreationally but also to self-medicate for conditions such as anxiety , anorexia , attention difficulties , cancer , and post-traumatic stress disorder.

Data 104

Data Cannabis Programs Pharmaceutical 104

Veriheal

OCTOBER 8, 2020

That makes a large number of pharmaceutical medications pumping through their symptoms. Now, research has revealed promising evidence that cannabis can be effective for treating those symptoms, essentially reducing the number of required pharmaceuticals. . What is Chemotherapy? What are the Side Effects of Chemotherapy?

Treatment 59

Treatment Research and Development Patients Pharmaceutical 59

Veriheal

AUGUST 31, 2020

Program between St. About Sinibaldo: Sinibaldo is an aspiring healthcare professional and a biomedical researcher in the Medical Scientist Training Program (M.D./Ph.D.) About Nishtha: Nishtha is pursuing neurology to become a physician-scientist in honor of her grandmother Nani who suffered from Alzheimer’s.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

JULY 30, 2019

The informed patients, cannabis industry employees, and clinicians find it equally difficult to keep updated on Florida’s latest medical marijuana program news and changes. . If more qualifying conditions are added, each cannabis physician can see a larger share of those 300,000 Florida patients in clinic, rather than just on paper.

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

JUNE 7, 2021

NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and its program development partner, Evvivax, S.R.L. Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. P1 (Brazil), and B.1.526 1.526 (New York) SARS-CoV-2 variants.

Clinical Trials 64

Clinical Trials Research and Development Therapy Supply Chain 64

The Cannigma

SEPTEMBER 12, 2021

Despite advancements in research, evidence regarding the health effects of cannabis use remains elusive and there is no consensus within the medical community about which conditions it can treat. Many states that disagreed with the federal approach to cannabis started their own medical marijuana programs, and made it accessible for patients.

THC 98

THC Research and Development Cannabinoids CBD 98

Cannabis Law Report

JANUARY 21, 2022

ADCL’s safeCircle program is a fully integrated testing platform for enterprise and educational institutions that provides a full range of COVID-19 diagnostic testing and associated services, including sample collection, test site infrastructure design and management, results tracking, and vaccination status management. The Linea 2.0

Collective 52

Collective Therapy Research and Development Supply Chain 52

Cannabis Law Report

JULY 1, 2021

These designations indicate that psychedelics may represent substantial improvements over existing treatments for mental health conditions. Essentially, due to their Schedule I status, it can be difficult to get research programs focused on psychedelics started, and they are limited in what they can achieve. Who might be left behind?

Law 105

Law Research and Development Therapy DEA 105

CannaTech

OCTOBER 14, 2018

California Hemp History. The state was well-positioned to permit this type of farming back in 2013 when Senate Bill 566 was enacted, conditionally approving an industrial hemp pilot program. Other independent studies are currently being conducted that address conditions such as autism and cancer.

Hemp 53

Hemp Research and Development Agriculture Seed-To-Sale 53

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. History of compliance with regulations and policies governing government regulated marijuana programs. Criterion 2.

Law 40

Law Marijuana Education Safety 40

Cannabis Law Report

JULY 20, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. History of compliance with regulations and policies governing government regulated marijuana programs. Criterion 2.

Law 40

Law Marijuana Education Cultivation 40

Cannabis Law Report

DECEMBER 30, 2019

Illinois and the US territory of Guam legalized adult-use cannabis and its retail sale, medical cannabis programs were enacted and expanded in several states, and 27 states considered legislation that would have legalized adult-use cannabis, a record-high. Continued Protections for State Legal Medical Programs. Erik Altieri.

Legislation 59

Legislation Patients Access Banking 59

Cannabis Law Report

NOVEMBER 15, 2021

CRO orders typically provide a means to evaluate LinearDNA within a customer’s preclinical development program. Key end-markets include Gov/Mil, textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. LineaRx has recorded an uptick in CRO orders for LinearDNA in recent quarters. Visit adnas.com for more information.

Research and Development 52

Research and Development Therapy Clinical Trials Supply Chain 52

SMPL

MAY 26, 2020

“There was a strong sense that this was really going to be something, if when people use these strains they have any kind of experience like the mice did in the laboratories,” said Martin Lee, a writer who at the time had been finishing a book about the social history of marijuana for Simon & Schuster.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

NOVEMBER 9, 2021

Key end-markets include Gov/Mil, textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. Hurry, 917-733-5573, sanjay.hurry@adnas.com Program Manager: Brian Viscount, 631-240-8877, brian.viscount@adnas.com Web: www.adnas.com Twitter: @APDN. Visit adnas.com for more information. Follow us on Twitter and LinkedIn.

Clinical Trials 52

Clinical Trials Research and Development Therapy Supply Chain 52

The Cannigma

DECEMBER 8, 2021

I help administer that program. Then from there, you can get them to, “Okay, it can help with a variety of medical conditions.” EG: The rest is history. Now, they would be able to get registered for the state’s medical cannabis program. We have the NORML legal committee as well. JMP: Here we are.

Access 81

Access Policy Patients Cannabis 81

The Cannigma

DECEMBER 22, 2021

At the moment, you said that they could potentially add more conditions. What conditions, or indications can doctors prescribe for in Israel at the moment? IR: Well, today, there is a closed list, basically, of conditions. It also doesn’t include doctor education and research into different conditions.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

JUNE 4, 2021

He is the creator and director of the television series Hamilton’s Pharmacopeia, in which he investigates the chemistry, history, and cultural impact of various psychoactive drugs. Brian Muraresku is the New York Times Bestselling author of The Immortality Key: The Secret History of the Religion with No Name. David Nutt. Drug Science.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

JULY 9, 2021

Further, numerous private companies have begun to research psychedelic therapy and develop new pharmaceutical compounds derived from psychedelic substances. Although ketamine is an FDA approved anesthetic with a long history of use in the clinical setting, it appears that ketamine may have uses beyond anesthetizing patients.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

OCTOBER 12, 2021

I have a long history working in similar environments in the cannabis and the spirits industry during my time with Aphria (now Tilray) and Diageo. He has an extensive history in executive leadership and governance roles of large, diverse organizations. and the U.K.

Extraction 52

Extraction Business Hash Events 52

Cannabis Law Report

AUGUST 12, 2019

For instance, when researching valuations, if your investment banker pulls down values for pharmaceutical testing labs, when he should have looked specifically at cannabis testing labs, that error could result in you leaving a substantial sum of money on the table.

Business 40

Business Banking Cannabis Concentrates 40

Cannabis Info

MARCH 26, 2019

It typically does NOT send users into addiction rehab programs. There was even a time in history for over 200 years when you could pay your taxes in America with hemp. In the mid 1930s, the M-word was created to tarnish the good image and phenomenal history of the hemp plant…as you will read. Realize the history that created it.

Marijuana 51

Marijuana Hemp Blood Pressure Oil 51

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma. With 600 million people, it is a big market.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

AUGUST 12, 2019

A Short History of CBD Oil. Federally Recognized Medical Conditions. After multiphase clinical trials were completed, an FDA panel recommended approval of a CBD-based pharmaceutical called Epidiolex for treatment of certain specific and rare types of juvenile epilepsy. A Comprehensive Guide to CBD Oil.

CBD 40

CBD Terpenes Oil Tincture 40